Skip to main content

Advertisement

Log in

Reply concerning “Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma” by Terheyden et al. (2004)

  • Letter to the Editors
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Avril MF, Aamdal S, Grob JJ, et al (2004) Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin Oncol 22:1118–1125

    Google Scholar 

  • Eskelin S, Pyrhönen S, Hahka-Kemppinen M, Tuomaala S (2003) A prognostic model and staging for metastatic uveal melanoma. Cancer 97:465–475

    Article  PubMed  Google Scholar 

  • Flaherty LE, Liu PY, Unger J, Sondak VK (1997) Comparison of patient characteristics and outcome between a single-institution phase II trial and a cooperative-group phase II trial with identical eligibility in metastatic melanoma. Am J Clin Oncol 20:600–604

    Google Scholar 

  • Pföhler C, Cree IA, Ugurel S, Kuwert C, et al (2003) Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study. Anticancer Drugs 14:337–340

    Article  PubMed  Google Scholar 

  • Serrone L, Zeuli M, Sega FM, Cognetti F (2000) Dacarbacine-based chemotherapy for metastatic melanoma: thirty-year experience overview. J Exp Clin Cancer Res 19:21–34

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Terheyden.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Terheyden, P., Bröcker, EB. & Becker, J.C. Reply concerning “Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma” by Terheyden et al. (2004). J Cancer Res Clin Oncol 131, 331 (2005). https://doi.org/10.1007/s00432-004-0631-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-004-0631-2

Keywords

Navigation